

Learn about Carvedilol drug interactions, including medications, supplements, and foods to avoid. Know what to tell your doctor before starting Carvedilol.
Carvedilol is a powerful medication that works on multiple receptors in your body — and that broad activity means it can interact with many other drugs, supplements, and even certain foods. Some interactions are dangerous. Others just require monitoring.
This guide covers the most important Carvedilol interactions so you know what to avoid and what to discuss with your doctor.
Drug interactions happen in a few ways:
Carvedilol is metabolized primarily by the liver enzyme CYP2D6, which is important because many common medications affect this enzyme.
These interactions are serious and usually require dose adjustments, close monitoring, or avoiding the combination entirely:
Verapamil (Calan, Verelan) and Diltiazem (Cardizem, Tiazac) combined with Carvedilol significantly increase the risk of dangerously slow heart rate (bradycardia), heart block, and severe low blood pressure. Both drug classes slow the heart, and the combination can be too much. If you need both a beta blocker and a calcium channel blocker, your doctor will monitor you closely with ECGs.
Digoxin (Lanoxin) is commonly used alongside Carvedilol for heart failure. However, Carvedilol increases digoxin blood levels by about 15%. Your doctor should monitor digoxin levels more frequently if you take both.
Clonidine (Catapres) and Carvedilol both lower blood pressure. The danger is during discontinuation: if Clonidine is stopped before Carvedilol, it can trigger severe rebound hypertension. If both need to be stopped, Carvedilol should be tapered first, then Clonidine several days later.
These medications slow down how your liver processes Carvedilol, which increases Carvedilol levels in your blood and amplifies side effects:
If you take one of these with Carvedilol, your doctor may need to reduce your Carvedilol dose.
Reserpine depletes catecholamines and combined with Carvedilol can cause additive bradycardia (very slow heart rate) and dangerous hypotension.
MAO inhibitors (Phenelzine/Nardil, Tranylcypromine/Parnate) used for depression can cause severe hypertensive crisis when combined with Carvedilol. These should generally not be used together.
Carvedilol can enhance the blood sugar-lowering effect of Insulin, Metformin, Glipizide (Glucotrol), and other diabetes medications. More importantly, it can mask the rapid heartbeat that typically warns diabetic patients of low blood sugar. Sweating remains a reliable warning sign. Monitor blood sugar more frequently.
Cyclosporine (Sandimmune, Neoral) — an immunosuppressant — can have its blood levels increased by Carvedilol. Dose adjustments and level monitoring are needed.
These interactions are worth knowing about and may require monitoring:
Don't forget about over-the-counter products and supplements:
Before starting Carvedilol, give your doctor a complete list of:
Keep a medication list in your wallet or phone. In an emergency, healthcare providers need to know you're on a beta blocker.
Carvedilol's broad mechanism of action makes it effective — but it also means more potential for interactions. The good news is that most interactions are manageable with proper monitoring and dose adjustments.
The most important thing you can do is be transparent with every healthcare provider about all the medications you take. Never start or stop a medication without consulting your doctor, especially while on Carvedilol.
For more about Carvedilol side effects or to find it at a pharmacy near you, visit Medfinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.